Figure 4

![Figure 4: Correlation analysis between Bifidobacterium abundance changes and clinical constipation outcomes supports a microbiota-mediated mechanism of action. The targeted enrichment of beneficial bacteria by xylo-oligosaccharides is associated with improved stool frequency and consistency.]()

> Source: Wanya Yi et al. "Xylo-oligosaccharides improve functional constipation by targeted enrichment of ." *Food science & nutrition*, 2024. PMID: [38370040](https://pubmed.ncbi.nlm.nih.gov/38370040/)

<figure>
  <img src="" alt="Correlation analysis between Bifidobacterium abundance changes and clinical constipation outcomes supports a microbiota-mediated mechanism of action. The targeted enrichment of beneficial bacteria by xylo-oligosaccharides is associated with improved stool frequency and consistency." />
  <figcaption>Figure 4. Correlation analysis between Bifidobacterium abundance changes and clinical constipation outcomes supports a microbiota-mediated mechanism of action. The targeted enrichment of beneficial bacteria by xylo-oligosaccharides is associated with improved stool frequency and consistency.<br>  Source: Wanya Yi et al. "Xylo-oligosaccharides improve functional constipation by targeted enrichment of ." <em>Food science & nutrition</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38370040/">38370040</a></figcaption>
</figure>